A phase II study of Chinese patients (pts) treated with <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC).

Lin Shen, Rui‐Hua Xu, Brian Lu et al.|Journal of Clinical Oncology|2016

Cited by 2